The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
Open accessAbstract
Background: Breast cancer is associated with a relatively good prognosis. Prognostic factors examined to date are related to early recurrence while those related to late recurrence and their countermeasures remain unclear. Therefore, we examined the factors related to late recurrence. Patients and Methods: From January 1980 to August 2012, 4,774 patients who underwent primary treatment and estrogen (ER) and progesterone receptor (PgR) assessment were enrolled in this study. The patients were divided into two groups, those with a follow-up period <10 years and those without any recurrence at 10 years but who continued follow-up examinations. Recurrence occurred in 711 patients followed up for <10 years and in 51 patients for ≥10 years. Results: The overall 10-year cumulative disease-free survival rate was 79.5%, and the recurrence rate at ≥10 years was 5.8%. A multivariate analysis revealed that the factors related to late recurrence were PgR positivity and positive nodes. This result differed from that for early recurrence in terms of ER/PgR, Ki-67 index and p53 overexpression. Conclusion: PgR positivity and lymph node metastases significantly correlated with late recurrence. Therefore, it is important to evaluate appropriate measures such as treatment period and treatment regimen for hormone-sensitive patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Research works printed but not linked: 3
- 10.1007/s10147-006-0601-6 · doi:10.1007/s10147-006-0601-6
- 10.1186/1477-7819-9-131 · doi:10.1186/1477-7819-9-131
- 10.1186/bcr2143 · doi:10.1186/bcr2143
Cited by
Items 701–787 of 787
Targeting the glucocorticoid receptor in breast and prostate cancers
Kach, J., Conzen, S. D., & Szmulewitz, R. Z. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7531 · Cited by 74
Rajendran, B. K., & Deng, C.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.17225 · Cited by 73
Tabach, Y., Milyavsky, M., Shats, I., Brosh, R., Zuk, O., Yitzhaky, A., Mantovani, R., Domany, E., Rotter, V., & Pilpel, Y. (2005) · Molecular Systems Biology · doi:10.1038/msb4100030 · Cited by 72
Yu, J. H., Steinberg, I., Davis, R. M., Malkovskiy, A. V., Zlitni, A., Radzyminski, R. K., Jung, K. O., Chung, D. T., Curet, L. D., D’Souza, A. L., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c07470 · Cited by 67
Zhang, G., Wang, Y., Chen, B., Guo, L., Cao, L., Ren, C., Wen, L., Li, K., Jia, M., Li, C., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.23 · Cited by 66
Leroux, A., Xu, S., Kundu, P., Muschelli, J., Smirnova, E., Chatterjee, N., & Crainiceanu, C. (2021) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa250 · Cited by 66
Sun, X., Tang, H., Chen, Y., Chen, Z., Hu, Z., Cui, Z., Tao, Y., Yuan, J., Fu, Y., Zhuang, Z., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00535-w · Cited by 66
Hippisley-Cox, J., & Coupland, C. (2015) · BMJ · doi:10.1136/bmj.h5441 · Cited by 63
Légaré, S., & Basik, M. (2016) · Molecular Endocrinology · doi:10.1210/me.2016-1072 · Cited by 63
Sethuraman, A., Brown, M., Krutilina, R., Wu, Z.-H., Seagroves, T. N., Pfeffer, L. M., & Fan, M. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1046-3 · Cited by 63
Rydén, L., Loman, N., Larsson, C., Hegardt, C., Vallon-Christersson, J., Malmberg, M., Lindman, H., Ehinger, A., Saal, L. H., & Borg, Å. (2018) · British Journal of Surgery · doi:10.1002/bjs.10741 · Cited by 62
Zhang, C., Zhang, X., Zhao, W., Zeng, C., Li, W., Li, B., Luo, X., Li, J., Jiang, J., Deng, B., et al. (2019) · Nano Research · doi:10.1007/s12274-019-2308-9 · Cited by 61
A microfluidic model for organ-specific extravasation of circulating tumor cells
Riahi, R., Yang, Y. L., Kim, H., Jiang, L., Wong, P. K., & Zohar, Y. (2014) · Biomicrofluidics · doi:10.1063/1.4868301 · Cited by 60
Chen, Z., Yuan, Y.-C., Wang, Y., Liu, Z., Chan, H. J., & Chen, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3446-8 · Cited by 59
Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor
Adhikary, S., Chakravarti, D., Terranova, C., Sengupta, I., Maitituoheti, M., Dasgupta, A., Srivastava, D. K., Ma, J., Raman, A. T., Tarco, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08986-5 · Cited by 57
Sviderskiy, V. O., Blumenberg, L., Gorodetsky, E., Karakousi, T. R., Hirsh, N., Alvarez, S. W., Terzi, E. M., Kaparos, E., Whiten, G. C., Ssebyala, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.016 · Cited by 56
Wu, J., Li, X., Teng, X., Rubin, D. L., Napel, S., Daniel, B. L., & Li, R. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1039-2 · Cited by 53
Omics Technologies Improving Breast Cancer Research and Diagnostics
Orsini, A., Diquigiovanni, C., & Bonora, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612690 · Cited by 52
Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis
Singleton, D. C., Rouhi, P., Zois, C. E., Haider, S., Li, J.-L., Kessler, B. M., Cao, Y., & Harris, A. L. (2015) · Oncogene · doi:10.1038/onc.2014.396 · Cited by 52
Mundi, P. S., Dela Cruz, F. S., Grunn, A., Diolaiti, D., Mauguen, A., Rainey, A. R., Guillan, K. C., Siddiquee, A., You, D., Realubit, R., et al. (2021) · doi:10.1101/2021.10.03.462951 · Cited by 51
Targeting triple-negative breast cancers with the Smac-mimetic birinapant
Lalaoui, N., Merino, D., Giner, G., Vaillant, F., Chau, D., Liu, L., Kratina, T., Pal, B., Whittle, J. R., Etemadi, N., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0541-0 · Cited by 51
Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing
Chan, J., Wang, X., Turner, J. A., Baldwin, N. E., & Gu, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz006 · Cited by 50
Identification of synergistic drug combinations using breast cancer patient-derived xenografts
Turner, T. H., Alzubi, M. A., & Harrell, J. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-58438-0 · Cited by 50
Laser direct-write onto live tissues: a novel model for studying cancer cell migration
Burks, H. E., Phamduy, T. B., Azimi, M. S., Saksena, J., Burow, M. E., Collins‐Burow, B. M., Chrisey, D. B., & Murfee, W. L. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25363 · Cited by 48
Kobayashi, K., Ito, Y., Matsuura, M., Fukada, I., Horii, R., Takahashi, S., Akiyama, F., Iwase, T., Hozumi, Y., Yasuda, Y., et al. (2016) · Surgery Today · doi:10.1007/s00595-015-1252-x · Cited by 45
A new concordance measure for risk prediction models in external validation settings
van Klaveren, D., Gönen, M., Steyerberg, E. W., & Vergouwe, Y. (2016) · Statistics in Medicine · doi:10.1002/sim.6997 · Cited by 48
Martini, R., Newman, L., & Davis, M. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10087-x · Cited by 46
Lessons and tips for designing a machine learning study using EHR data
Arbet, J., Brokamp, C., Meinzen-Derr, J., Trinkley, K. E., & Spratt, H. M. (2021) · Journal of Clinical and Translational Science · doi:10.1017/cts.2020.513 · Cited by 46
A Review of Imputation Strategies for Isobaric Labeling-Based Shotgun Proteomics
Bramer, L. M., Irvahn, J., Piehowski, P. D., Rodland, K. D., & Webb-Robertson, B.-J. M. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00123 · Cited by 47
Kumegawa, K., Takahashi, Y., Saeki, S., Yang, L., Nakadai, T., Osako, T., Mori, S., Noda, T., Ohno, S., Ueno, T., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00438-6 · Cited by 45
Self-citationBailey, C. M., Liu, Y., Peng, G., Zhang, H., He, M., Sun, D., Zheng, P., Liu, Y., & Wang, Y. (2020) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2020.102278 · Cited by 44
HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer
Gogiashvili, M., Nowacki, J., Hergenröder, R., Hengstler, J. G., Lambert, J., & Edlund, K. (2019) · Metabolites · doi:10.3390/metabo9020019 · Cited by 44
EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy
Zhou, X., Wang, M., Katsyv, I., Irie, H., & Zhang, B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty325 · Cited by 43
Digital PCR: From early developments to its future application in clinics
Trouchet, A., Gines, G., Benhaim, L., & Taly, V. (2025) · Lab on a Chip · doi:10.1039/d5lc00055f · Cited by 43
Sarda, S., Das, A., Vinson, C., & Hannenhalli, S. (2017) · Genome Research · doi:10.1101/gr.212050.116 · Cited by 43
BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.
Biswas, K., Philip, S., Yadav, A., Martin, B. K., Burkett, S., Singh, V., Babbar, A., North, S. L., Chang, S., & Sharan, S. K. (2018) · Nature Communications · doi:10.1038/s41467-018-03020-6 · Cited by 41
EHealth acceptance and new media preferences for therapy assistance among breast cancer patients.
Drewes, C., Kirkovits, T., Schiltz, D., Schinkoethe, T., Haidinger, R., Goldmann-Posch, U., Harbeck, N., & Wuerstlein, R. (2016) · JMIR Cancer · doi:10.2196/cancer.5711 · Cited by 40
GO-PCA: An Unsupervised Method to Explore Gene Expression Data Using Prior Knowledge
Wagner, F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143196 · Cited by 35
Assessing the incremental role of novel and emerging risk factors.
Cook, N. R. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0084-x · Cited by 39
Ayoub, N., Al-Shami, K., Alqudah, M. A. Y., & Mhaidat, N. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s148604 · Cited by 38
Hu, B., Xin, Y., Hu, G., Li, K., & Tan, Y. (2023) · APL Bioengineering · doi:10.1063/5.0156628 · Cited by 36
Carrillo-Perez, F., Pizurica, M., Zheng, Y., Nandi, T. N., Madduri, R., Shen, J., & Gevaert, O. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01193-8 · Cited by 37
Management of phosphatidylinositol-3-kinase inhibitor-associated hyperglycemia
Goncalves, M. D., & Farooki, A. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354211073163 · Cited by 37
The regulatory role of miRNAs on VDR in breast cancer
Singh, T., & Adams, B. D. (2017) · Transcription · doi:10.1080/21541264.2017.1317695 · Cited by 37
Dong, Q., Gao, H., Shi, Y., Zhang, F., Gu, X., Wu, A., Wang, D., Chen, Y., Bandyopadhyay, A., Yeh, I.-T., et al. (2016) · Aging · doi:10.18632/aging.101082 · Cited by 29
The center for causal discovery of biomedical knowledge from big data
Cooper, G. F., Bahar, I., Becich, M. J., Benos, P. V., Berg, J., Espino, J., Glymour, C., Jacobson, R. C., Kienholz, M., Lee, A. V., et al. (2015) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv059 · Cited by 36
Gallagher, E. J., Moore, H., Lacouture, M. E., Dent, S. F., Farooki, A., Goncalves, M. D., Isaacs, C., Johnston, A., Juric, D., Quandt, Z., et al. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00613-x · Cited by 36
Oncology providers’ perspectives on endocrine therapy prescribing and management
Wheeler, S., Roberts, M., Bloom, D., Reeder-Hayes, K., Espada, M., Peppercorn, J., Golin, C., & Earp, J. A. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s95594 · Cited by 31
The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells
Synnott, N. C., Madden, S. F., Bykov, V. J. N., Crown, J., Wiman, K. G., & Duffy, M. J. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.08.009 · Cited by 35
CRISPR screens identify gene targets at breast cancer risk loci
Tuano, N. K., Beesley, J., Manning, M., Shi, W., Perlaza-Jimenez, L., Malaver-Ortega, L. F., Paynter, J. M., Black, D., Civitarese, A., McCue, K., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02898-w · Cited by 30
Yan, K. K., Zhao, H., & Pang, H. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1982-4 · Cited by 34
Qi, F., Qin, W., & Zang, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.9884 · Cited by 32
Phenotype prediction from single-cell RNA-seq data using attention-based neural networks
Mao, Y., Lin, Y.-Y., Wong, N. K. Y., Volik, S., Sar, F., Collins, C., & Ester, M. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae067 · Cited by 31
Zhao, N., Kabotyanski, E. B., Saltzman, A. B., Malovannaya, A., Yuan, X., Reineke, L. C., Lieu, N., Gao, Y., Pedroza, D. A., Calderon, S. J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci172503 · Cited by 30
Tsigelny, I. F., Wheler, J. J., Greenberg, J. P., Kouznetsova, V. L., Stewart, D. J., Bazhenova, L., & Kurzrock, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3472 · Cited by 30
Park, J.-H., Rasch, M. G., Qiu, J., Lund, I. K., & Egeblad, M. (2015) · Neoplasia · doi:10.1016/j.neo.2015.04.003 · Cited by 29
Wang, Y. K., Print, C. G., & Crampin, E. J. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-102 · Cited by 28
Bii, V. M., Rae, D. T., & Trobridge, G. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6232 · Cited by 28
Lin, T., Gu, J., Qu, K., Zhang, X., Ma, X., Miao, R., Xiang, X., Fu, Y., Niu, W., She, J., et al. (2018) · Aging · doi:10.18632/aging.101563 · Cited by 26
Joe, N. S., Godet, I., Milki, N., Ain, N. U. I., Oza, H. H., Riggins, G. J., & Gilkes, D. M. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01591-3 · Cited by 24
Sparano, J. A., Goldstein, L. J., Childs, B. H., Shak, S., Brassard, D., Badve, S., Baehner, F. L., Bugarini, R., Rowley, S., Perez, E. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3357 · Cited by 22
Upreti, M., Jyoti, A., Johnson, S. E., Swindell, E. P., Napier, D., Sethi, P., Chan, R., Feddock, J. M., Weiss, H. L., O’Halloran, T. V., et al. (2106) · Oncotarget · doi:10.18632/oncotarget.9490 · Cited by 21
Evolution of chromosome-arm aberrations in breast cancer through genetic network rewiring
Kuzmin, E., Baker, T. M., Lesluyes, T., Monlong, J., Abe, K. T., Coelho, P. P., Schwartz, M., Del Corpo, J., Zou, D., Morin, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113988 · Cited by 20
Bidimensional linked matrix factorization for pan-omics pan-cancer analysis
Lock, E. F., Park, J. Y., & Hoadley, K. A. (2022) · The Annals of Applied Statistics · doi:10.1214/21-aoas1495 · Cited by 19
Time‐to‐event prediction using survival analysis methods for Alzheimer's disease progression
Sharma, R., Anand, H., Badr, Y., & Qiu, R. G. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12229 · Cited by 19
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)
Shelby, R. A., Dorfman, C. S., Bosworth, H. B., Keefe, F., Sutton, L., Owen, L., Corsino, L., Erkanli, A., Reed, S. D., Arthur, S. S., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.11.010 · Cited by 18
Rotundo, M. S., Galeano, T., Tassone, P., & Tagliaferri, P. (2016) · Oncotarget · doi:10.18632/oncotarget.7446 · Cited by 18
Kar, S. P., Considine, D. P. C., Tyrer, J. P., Plummer, J. T., Chen, S., Dezem, F. S., Barbeira, A. N., Rajagopal, P. S., Rosenow, W. T., Moreno, F., et al. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100042 · Cited by 18
Sivik, T., Gunnarsson, C., Fornander, T., Nordenskjöld, B., Skoog, L., Stål, O., & Jansson, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040568 · Cited by 17
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Wendt, C., Lindblom, A., Arver, B., von Wachenfeldt, A., & Margolin, S. (2015) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-015-0036-z · Cited by 16
Ledbetter, M. K., Tabacu, L., Leroux, A., Crainiceanu, C. M., & Smirnova, E. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107303 · Cited by 16
Davis, R. J., Swanger, J., Hughes, B. T., & Clurman, B. E. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00657-16 · Cited by 15
Choi, E., Jeon, K., Lee, H., Mun, G., Kim, J., Shin, J., Kwon, Y., Na, Y., & Lee, Y. (2024) · Cancer Science · doi:10.1111/cas.16174 · Cited by 15
PTEN is required to maintain luminal epithelial homeostasis and integrity in the adult mammary gland
Shore, A. N., Chang, C.-H., Kwon, O.-J., Weston, M. C., Zhang, M., Xin, L., & Rosen, J. M. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2015.10.023 · Cited by 15
On the inconsistency of ℓ 1-penalised sparse precision matrix estimation
Heinävaara, O., Leppä-aho, J., Corander, J., & Honkela, A. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1309-x · Cited by 14
Covariate‐adjusted measures of discrimination for survival data
White, I. R., Rapsomaniki, E., & for the Emerging Risk Factors Collaboration (2015) · Biometrical Journal · doi:10.1002/bimj.201400061 · Cited by 13
Karter, A. J., Parker, M. M., Moffet, H. H., Lipska, K. J., Laiteerapong, N., Grant, R. W., Lee, C., & Huang, E. S. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08219-y · Cited by 13
(2022) · PubMed Central · Cited by 12
BAUERSCHMITZ, G., HÜCHEL, S., GALLWAS, J., & GRÜNDKER, C. (2023) · Cancer Genomics - Proteomics · doi:10.21873/cgp.20403 · Cited by 11
Shen, M., Xie, Q., Zhang, R., Yu, C., & Xiao, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1175021 · Cited by 11
A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats
Magaki, M., Ishii, H., Yamasaki, A., Kitai, Y., Kametani, S., Nakai, R., Dabid, A., Tsuda, H., & Ohnishi, T. (2017) · Journal of Toxicologic Pathology · doi:10.1293/tox.2016-0052 · Cited by 10
Hashimoto Takigami, N., Kuniyoshi, S., Miki, Y., Tamaki, K., Kamada, Y., Uehara, K., Tsuchiya, S., Terukina, S., Iwabuchi, E., Kanai, A., et al. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06288-3 · Cited by 10
A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia
(2023) · doi:10.1016/j.celrep.2023.113001 · Cited by 8
Mills, M., Liveringhouse, C., Lee, F., Nanda, R. H., Ahmed, K. A., Washington, I. R., Thapa, R., Fridley, B. L., Blumencranz, P., Extermann, M., et al. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.08.007 · Cited by 7
Lee, H. G., Sholle, E., Beecy, A., Al’Aref, S., & Peng, Y. (2021) · Proceedings of the 2021 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies · doi:10.18653/v1/2021.naacl-main.358 · Cited by 7
Jongbloed, E. M., Jansen, M. P. H. M., de Weerd, V., Helmijr, J. A., Beaufort, C. M., Reinders, M. J. T., van Marion, R., van IJcken, W. F. J., Sonke, G. S., Konings, I. R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-37409-1 · Cited by 6
Proteome-wide copy-number estimation from transcriptomics
Sweatt, A. J., Griffiths, C. D., Groves, S. M., Paudel, B. B., Wang, L., Kashatus, D. F., & Janes, K. A. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00064-3 · Cited by 5
Metadata
- Authors
- Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N.
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 85
- Issue
- 2
- Pages
- 100-110
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W2044702943
- Cited by
- 13,166
- References
- 236
- FWCI
- 323.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.